• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性胰腺实质萎缩,一种预测胰腺导管腺癌发生的影像学表现:一项病例对照研究。

Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case-control study.

作者信息

Koiwai Akinobu, Hirota Morihisa, Matsuura Tomonori, Itoh Takehito, Kin Ryo, Katayama Tomofumi, Endo Katsuya, Takasu Atsuko, Kogure Takayuki, Murakami Kazuhiro, Satoh Kennichi

机构信息

Division of Gastroenterology Tohoku Medical and Pharmaceutical University Sendai Japan.

Division of Radiology Tohoku Medical and Pharmaceutical University Sendai Japan.

出版信息

JGH Open. 2023 Jun 2;7(6):445-452. doi: 10.1002/jgh3.12930. eCollection 2023 Jun.

DOI:10.1002/jgh3.12930
PMID:37359111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10290266/
Abstract

BACKGROUND AND AIM

Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer, partly because its early detection is difficult. This study aimed to identify computed tomography (CT) findings associated with PDAC prior to diagnosis.

METHODS

Past CT images were retrospectively collected from the PDAC group ( = 54) and the control group ( = 90). The following imaging findings were compared: pancreatic mass, main pancreatic duct (MPD) dilatation with or without cutoff, cyst, chronic pancreatitis with calcification, partial parenchymal atrophy (PPA), and diffuse parenchymal atrophy (DPA). In the PDAC group, CT findings were examined during the pre-diagnostic period and 6-36 months and 36-60 months before diagnosis. Multivariate analyses were performed using logistic regression.

RESULTS

MPD dilatation with cutoff ( < 0.0001) and PPA ( = 0.023) were identified as significant imaging findings 6-36 months before diagnosis. DPA was identified as a novel imaging finding at 6-36 months ( = 0.003) and 36-60 months ( = 0.009) before diagnosis.

CONCLUSION

DPA, MPD dilatation with cutoff, and PPA were identified as imaging findings associated with pre-diagnostic PDAC.

摘要

背景与目的

胰腺导管腺癌(PDAC)是一种致命性癌症,部分原因是其早期检测困难。本研究旨在确定诊断前与PDAC相关的计算机断层扫描(CT)表现。

方法

回顾性收集PDAC组(n = 54)和对照组(n = 90)过去的CT图像。比较以下影像学表现:胰腺肿块、主胰管(MPD)扩张伴或不伴截断、囊肿、伴有钙化的慢性胰腺炎、部分实质萎缩(PPA)和弥漫性实质萎缩(DPA)。在PDAC组中,在诊断前时期以及诊断前6 - 36个月和36 - 60个月检查CT表现。使用逻辑回归进行多变量分析。

结果

截断性MPD扩张(P < 0.0001)和PPA(P = 0.023)被确定为诊断前6 - 36个月的重要影像学表现。DPA被确定为诊断前6 - 36个月(P = 0.003)和36 - 60个月(P = 0.009)的一种新的影像学表现。

结论

DPA、截断性MPD扩张和PPA被确定为与诊断前PDAC相关的影像学表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/aafb48bec60e/JGH3-7-445-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/8ad5d031f775/JGH3-7-445-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/bb9713dc1963/JGH3-7-445-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/444635150497/JGH3-7-445-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/aafb48bec60e/JGH3-7-445-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/8ad5d031f775/JGH3-7-445-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/bb9713dc1963/JGH3-7-445-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/444635150497/JGH3-7-445-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edd8/10290266/aafb48bec60e/JGH3-7-445-g004.jpg

相似文献

1
Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case-control study.弥漫性胰腺实质萎缩,一种预测胰腺导管腺癌发生的影像学表现:一项病例对照研究。
JGH Open. 2023 Jun 2;7(6):445-452. doi: 10.1002/jgh3.12930. eCollection 2023 Jun.
2
Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study.胰腺癌计算机断层扫描表现的时间进程直至诊断:一项大规模多中心研究。
United European Gastroenterol J. 2024 Jul;12(6):761-771. doi: 10.1002/ueg2.12557. Epub 2024 Mar 7.
3
CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.1 年以上后临床诊断为 I 期胰腺导管腺癌时与胰腺相关的 CT 异常:病例对照研究。
AJR Am J Roentgenol. 2021 Dec;217(6):1353-1364. doi: 10.2214/AJR.21.26014. Epub 2021 Jun 23.
4
Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study.胰腺癌患者诊断前计算机断层扫描中常观察到胰腺局灶性实质萎缩:一项病例对照研究。
Diagnostics (Basel). 2021 Sep 17;11(9):1693. doi: 10.3390/diagnostics11091693.
5
Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.孤立性主胰管扩张:CT对良恶性病因的鉴别
AJR Am J Roentgenol. 2017 Nov;209(5):1046-1055. doi: 10.2214/AJR.17.17963. Epub 2017 Aug 31.
6
Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis.主胰管未扩张的胰腺导管腺癌的临床特征及预后影响:一项单中心回顾性分析
Diagnostics (Basel). 2023 Mar 3;13(5):963. doi: 10.3390/diagnostics13050963.
7
Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy.不明原因的主胰管扩张:癌前病变或恶性肿瘤的病因和危险因素。
Surg Endosc. 2023 May;37(5):3684-3690. doi: 10.1007/s00464-022-09854-y. Epub 2023 Jan 13.
8
Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.漏诊的胰腺导管腺癌:对诊断前磁共振成像早期影像表现的评估
Eur J Radiol. 2015 Aug;84(8):1473-1479. doi: 10.1016/j.ejrad.2015.05.012. Epub 2015 May 18.
9
Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.使用对比增强计算机断层扫描鉴别慢性肿块型胰腺炎与胰腺导管腺癌。
Cancer Manag Res. 2019 Aug 20;11:7857-7866. doi: 10.2147/CMAR.S217033. eCollection 2019.
10
Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.用于鉴别自身免疫性胰腺炎与胰腺腺癌的MRI特征的系统评价和荟萃分析。
Eur Radiol. 2022 Oct;32(10):6691-6701. doi: 10.1007/s00330-022-08816-1. Epub 2022 Apr 29.

引用本文的文献

1
Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans.利用诊断前CT扫描中主胰管的特征提前10年预测胰腺导管腺癌的发生
Cancers (Basel). 2025 Jun 4;17(11):1886. doi: 10.3390/cancers17111886.
2
Comparison between solid pseudopapillary neoplasms of the pancreas and pancreatic ductal adenocarcinoma with cystic changes using computed tomography.利用计算机断层扫描对胰腺实性假乳头状肿瘤与伴有囊性改变的胰腺导管腺癌进行比较。
World J Radiol. 2024 Jun 28;16(6):211-220. doi: 10.4329/wjr.v16.i6.211.

本文引用的文献

1
Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study.胰腺癌患者诊断前计算机断层扫描中常观察到胰腺局灶性实质萎缩:一项病例对照研究。
Diagnostics (Basel). 2021 Sep 17;11(9):1693. doi: 10.3390/diagnostics11091693.
2
Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ.胰腺局灶性实质萎缩:是存在高级别胰腺上皮内瘤变而无浸润性癌(原位癌)的重要征象。
Pancreatology. 2020 Dec;20(8):1689-1697. doi: 10.1016/j.pan.2020.09.020. Epub 2020 Sep 30.
3
Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
计算机断层扫描在胰腺导管腺癌的诊断前:进展阶段和早期干预的潜在益处:一项回顾性研究。
Pancreatology. 2020 Oct;20(7):1495-1501. doi: 10.1016/j.pan.2020.07.410. Epub 2020 Aug 11.
4
Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients.胰腺实质部分萎缩是诊断包括原位癌在内的小胰腺癌(≤10mm)的一项新的特异性发现:与局限性良性主胰管狭窄患者的比较。
Diagnostics (Basel). 2020 Jul 1;10(7):445. doi: 10.3390/diagnostics10070445.
5
Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.主胰管扩张作为遗传性胰腺癌监测计划中发现的小胰导管腺癌的首发表现。
HPB (Oxford). 2019 Oct;21(10):1371-1375. doi: 10.1016/j.hpb.2019.02.013. Epub 2019 Mar 22.
6
Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience.基于胰腺癌患者内镜超声检查的非酒精性脂肪性胰腺疾病作为胰腺癌危险因素:单中心经验
JGH Open. 2017 Dec 23;2(1):4-7. doi: 10.1002/jgh3.12032. eCollection 2018 Feb.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Multicenter study of early pancreatic cancer in Japan.日本多中心早期胰腺癌研究。
Pancreatology. 2018 Jan;18(1):61-67. doi: 10.1016/j.pan.2017.11.007. Epub 2017 Nov 20.
9
Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE).急性胰腺炎伴胰腺原位癌,通过连续胰液抽吸细胞学检查(SPACE)诊断为胰腺原位癌伴局灶性脂肪替代。
Clin J Gastroenterol. 2017 Dec;10(6):541-545. doi: 10.1007/s12328-017-0776-6. Epub 2017 Oct 6.
10
Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.《2016年日本胰腺学会胰腺癌临床实践指南:概要》
Pancreas. 2017 May/Jun;46(5):595-604. doi: 10.1097/MPA.0000000000000816.